ANG Lifesciences India Ltd. is proposing an Initial Public Offering (IPO) on the BSE SME platform under the SME category.
Subscription opens 29 Aug 2017, closes 31 Aug 2017. Listing expected 08 Sep 2017. Apply via ASBA or UPI.
ANG Lifesciences India Ltd. proposes to utilise the net proceeds from the Issue for the following objects:
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 1,600 | ₹128,000 |
| Retail (Max) | 13 | 20,800 | ₹1,664,000 |
| sNII (Min) | 14 | 22,400 | ₹1,792,000 |
| bNII (Min) | 68 | 108,800 | ₹8,704,000 |
| Particulars | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Revenue from Operations | N/A | N/A | N/A |
| EBITDA | N/A | N/A | N/A |
| Profit After Tax (PAT) | N/A | N/A | N/A |
| Net Worth | N/A | N/A | N/A |
| Total Assets | N/A | N/A | N/A |
| Reserves & Surplus | N/A | N/A | N/A |
| Total Borrowings | N/A | N/A | N/A |